Innoviva, INC Form 4 insider transactions

Innoviva, Inc. CFO Stephen Basso acquired shares via an employee plan and disposed of shares to cover tax obligations.

Innoviva, Inc. CEO Pavel Raifeld acquired shares via an employee stock purchase plan and disposed of shares to cover tax obligations.

Innoviva Chief Accounting Officer Marianne Zhen reported the withholding of 1,127 shares to cover tax obligations related to equity vesting.

Innoviva, Inc. reports the grant of restricted stock units and stock options to Director Josephine Linden upon her board appointment.

Innoviva Inc. Chief Accounting Officer Marianne Zhen acquired 12,766 shares of common stock and was granted stock options.

Innoviva, Inc. reports that Director Sarah J. Schlesinger was granted stock options and restricted stock units following the 2026 annual meeting.

Innoviva, Inc. reports that Chief Financial Officer Stephen Basso was granted stock options and restricted stock units, subject to stockholder approval and vesting schedules.

Innoviva, Inc. director Derek Small acquired restricted stock units and stock options following the company's 2026 annual meeting.

Innoviva, Inc. director Jules Haimovitz acquired 9,786 shares of common stock and 10,000 non-statutory stock options.

Innoviva's Chief Financial Officer, Stephen Basso, disposed of 1,244 shares of common stock to cover tax withholding obligations related to equity vesting.

Innoviva CEO Pavel Raifeld disposed of 2,986 shares of common stock to cover tax obligations related to equity vesting.

Innoviva's Chief Accounting Officer, Marianne Zhen, disposed of 2,460 common shares to cover tax obligations related to equity vesting.

Innoviva's Chief Financial Officer, Stephen Basso, reported recent stock transactions including an Employee Stock Purchase Plan acquisition and shares withheld for tax obligations.

Innoviva's Chief Accounting Officer, Marianne Zhen, disposed of 992 shares of common stock to cover tax obligations associated with the quarterly vesting of employee equity grants.

Innoviva, Inc. Chief Financial Officer Stephen Basso was granted 27,609 restricted stock units, vesting over time with accelerated provisions.

Innoviva Director Pavel Raifeld increased his beneficial ownership to 162,276 shares through an Employee Stock Purchase Plan acquisition and a significant restricted stock unit grant.

Innoviva's Chief Financial Officer, Stephen Basso, disposed of 237 shares of common stock to cover tax withholding obligations related to equity vesting.

Innoviva's Chief Accounting Officer, Marianne Zhen, had 991 shares withheld by the company to cover tax obligations related to equity vesting.

Marianne Zhen, Chief Accounting Officer of Innoviva, Inc., reports the withholding of shares to cover income tax obligations related to equity grants.

Stephen Basso, CFO of Innoviva, Inc., reports acquisition of shares through the Employee Stock Purchase Plan and shares withheld for tax obligations.

Director Derek Small reports the acquisition of stock and options in Innoviva, Inc. following the company's annual meeting.

Director Mark DiPaolo reports acquisition of Innoviva shares and options following the company's 2025 annual meeting of stockholders.

Director Sarah J. Schlesinger reports the acquisition of Innoviva, Inc. stock and options following the company's 2025 annual meeting of stockholders.

Director Jules Haimovitz reports acquisition of Innoviva stock and options following the company's 2025 annual meeting of stockholders.

Marianne Zhen, Chief Accounting Officer of Innoviva, Inc., reports the acquisition of restricted stock units and non-statutory stock options.

Stephen Basso, CFO of Innoviva, Inc., reports the acquisition of restricted stock units and non-statutory stock options.

Director Pavel Raifeld reports acquisition of Innoviva stock through an employee stock purchase plan and grants of restricted stock units and non-statutory stock options.

Alexander Denner and Sarissa Capital Management LP amend their Form 4 filing to reflect that they may no longer be deemed to beneficially own 10% or more of Innoviva's common stock and are no longer subject to Section 16.

Sarissa Capital Management, led by Alexander J. Denner, sold 1,518,295 shares of Innoviva, Inc. (INVA) between March 4 and March 6, 2025.

Marianne Zhen, Chief Accounting Officer of Innoviva, Inc., reports the withholding of shares by the issuer to cover income tax obligations related to equity grants.